Cantitate/Preț
Produs
Total produse
Vezi coșul
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances de Franco M. Muggia

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: Cancer Treatment and Research, cartea 42

Editat de Franco M. Muggia
en Limba Engleză Paperback – 5 oct 2011

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 109206 lei  6-8 săpt.
  Springer Us – 5 oct 2011 109206 lei  6-8 săpt.
Hardback (1) 109899 lei  6-8 săpt.
  Springer Us – 30 noi 1988 109899 lei  6-8 săpt.

Din seria Cancer Treatment and Research

  • 5% T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies
    Preț: 110303 lei
  • 5% HIV/AIDS-Associated Viral Oncogenesis
    Preț: 72632 lei
  • 5% Tumor Microenvironment
    Preț: 78758 lei
  • 5% Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies
    Preț: 103793 lei
  • 5% Cancer Drug Safety and Public Health Policy: A Changing Landscape
    Preț: 103264 lei
  • 5% Therapeutic Approaches in Cancer Treatment
    Preț: 104177 lei
  • 5% Targeting the DNA Damage Response for Cancer Therapy
    Preț: 91742 lei
  • 5% Threshold Decision-making in Clinical Medicine: With Practical Application to Hematology and Oncology
    Preț: 71902 lei
  • 5% Epigenetics in Oncology
    Preț: 92018 lei
  • 5% Nutrition and Dietary Interventions in Cancer
    Preț: 104088 lei
  • 5% Adrenal and Endocrine Tumors in Children: Adrenal Cortical Carcinoma and Multiple Endocrine Neoplasia
    Preț: 72119 lei
  • 15% Bayesian Methods in Reliability
    Preț: 70010 lei
  • 5% Lung Cancer 1
    Preț: 37038 lei
  • 5% Gynecologic Oncology
    Preț: 211684 lei
  • 5% Palliative Care and Rehabilitation of Cancer Patients
    Preț: 141408 lei
  • 5% Advances in Allogeneic Hematopoietic Stem Cell Transplantation
    Preț: 142416 lei
  • 5% HIV & HTLV-I Associated Malignancies
    Preț: 110669 lei
  • 5% Thoracic Oncology
    Preț: 129762 lei
  • 5% Cancer Chemoprevention
    Preț: 110322 lei
  • 5% Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium
    Preț: 109444 lei
  • 5% Liver-Directed Therapy for Primary and Metastatic Liver Tumors
    Preț: 109645 lei
  • 5% Biology and Management of Lung Cancer
    Preț: 141356 lei
  • 5% Non-Myeloablative Allogeneic Transplantation
    Preț: 72010 lei
  • 5% Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer
    Preț: 70677 lei
  • 5% Clinically Relevant Resistance in Cancer Chemotherapy
    Preț: 73107 lei
  • 5% Biostatistical Applications in Cancer Research
    Preț: 141480 lei
  • 5% Head and Neck Cancer
    Preț: 110872 lei
  • 5% Signal Transduction in Cancer
    Preț: 109812 lei
  • 5% Kidney Cancer
    Preț: 109222 lei
  • 5% Angiogenesis in Brain Tumors
    Preț: 109956 lei
  • 5% The Biology of Skeletal Metastases
    Preț: 110633 lei
  • 5% Molecular Targeting and Signal Transduction
    Preț: 109681 lei

Preț: 109206 lei

Preț vechi: 114954 lei
-5% Nou

Puncte Express: 1638
Preț estimativ în valută:
20899€ • 21791$ • 17369£

Carte tipărită la comandă

Livrare economică 21 martie-04 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461289814
ISBN-10: 1461289815
Pagini: 256
Ilustrații: XIV, 238 p.
Dimensiuni: 155 x 235 x 13 mm
Greutate: 0.36 kg
Ediția:1989
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

I. Concepts.- 1. Alkylating agents: Mechanisms and modulation.- 2. Reduced folates and fluoropyrimidine antitumor efficacy.- 3. Laboratory aspects of multidrug resistance.- II. Initial clinical investigations.- 4. Multidrug resistance: clinical findings and implications.- 5. Current status of trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties.- 6. Daunomycin and doxorubicin LYM-1-drug conjugates for the treatment of malignant lymphomas.- 7. Phase I trials: Role of the nurse investigator.- III. Therapeutic advances.- 8. The role of chemotherapy in the treatment of squamous cell tumors of the esophagus.- 9. Systemic chemotherapy of transitional cell carcinoma of the urothelium.- 10. Nasopharyngeal cancer, undifferentiated type: The medical oncologist’s viewpoint.- 11. Primary central nervous system lymphomas.